Cambridge Investment Research Advisors’s Merck MRK Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.3M	Buy	469,217 +57,875	+14%	+$6.77M	0.14%	136
2026 Q1	$49.5M	Sell	411,342 -10,588	-3%	-$1.22M	0.13%	152
2025 Q4	$44.4M	Buy	421,930 +15,560	+4%	+$1.46M	0.12%	168
2025 Q3	$34.1M	Sell	406,370 -41,849	-9%	-$3.45M	0.09%	214
2025 Q2	$35.5M	Sell	448,219 -4,920	-1%	-$391K	0.11%	187
2025 Q1	$40.7M	Buy	453,139 +2,348	+0.5%	+$219K	0.14%	140
2024 Q4	$44.8M	Sell	450,791 -13,408	-3%	-$1.38M	0.15%	124
2024 Q3	$52.7M	Buy	464,199 +21,906	+5%	+$2.6M	0.18%	100
2024 Q2	$54.8M	Buy	442,293 +7,723	+2%	+$995K	0.2%	89
2024 Q1	$57.3M	Sell	434,570 -16,732	-4%	-$2.06M	0.22%	82
2023 Q4	$49.2M	Sell	451,302 -7,497	-2%	-$778K	0.21%	86
2023 Q3	$47.2M	Sell	458,799 -20,202	-4%	-$2.18M	0.22%	86
2023 Q2	$55.3M	Buy	479,001 +120	+0%	+$13.6K	0.25%	70
2023 Q1	$50.9M	Buy	478,881 +314	+0.1%	+$33.9K	0.25%	70
2022 Q4	$53.1M	Buy	478,567 +31,619	+7%	+$3.23M	0.28%	68
2022 Q3	$38.5M	Buy	446,948 +3,222	+0.7%	+$288K	0.22%	84
2022 Q2	$40.5M	Buy	443,726 +16,344	+4%	+$1.45M	0.22%	88
2022 Q1	$35.1M	Sell	427,382 -12,536	-3%	-$988K	0.16%	118
2021 Q4	$33.7M	Buy	439,918 +10,846	+3%	+$864K	0.15%	137
2021 Q3	$32.2M	Sell	429,072 -18,533	-4%	-$1.41M	0.16%	121
2021 Q2	$34.8M	Sell	447,605 -36,750	-8%	-$2.73M	0.17%	120
2021 Q1	$35.6M	Buy	484,355 +24,571	+5%	+$1.81M	0.19%	97
2020 Q4	$35.9M	Buy	459,784 +15,796	+4%	+$1.21M	0.21%	87
2020 Q3	$35.1M	Sell	443,988 -864	-0.2%	-$67.7K	0.24%	79
2020 Q2	$32.8M	Buy	444,852 +24,732	+6%	+$1.86M	0.25%	80
2020 Q1	$30.8M	Buy	420,120 +3,219	+0.8%	+$253K	0.3%	71
2019 Q4	$36.2M	Buy	416,901 +58,497	+16%	+$4.8M	0.28%	73
2019 Q3	$28.8M	Buy	358,404 +1,835	+0.5%	+$147K	0.25%	80
2019 Q2	$28.5M	Buy	356,569 +15,583	+5%	+$1.19M	0.26%	82
2019 Q1	$27.1M	Sell	340,986 -21,842	-6%	-$1.63M	0.26%	79
2018 Q4	$26.5M	Buy	362,828 +17,769	+5%	+$1.25M	0.29%	69
2018 Q3	$23.4M	Sell	345,059 -6,427	-2%	-$409K	0.22%	95
2018 Q2	$20.4M	Buy	351,486 +1,591	+0.5%	+$89.8K	0.22%	99
2018 Q1	$18.2M	Buy	349,895 +81,911	+31%	+$4.42M	0.21%	105
2017 Q4	$14.4M	Buy	267,984 +25,662	+11%	+$1.42M	0.17%	125
2017 Q3	$14.8M	Buy	242,322 +9,937	+4%	+$602K	0.2%	101
2017 Q2	$14.2M	Buy	232,385 +33,585	+17%	+$2.04M	0.21%	95
2017 Q1	$12.1M	Sell	198,800 -6,085	-3%	-$369K	0.21%	99
2016 Q4	$11.5M	Buy	204,885 +2,092	+1%	+$122K	0.22%	96
2016 Q3	$12.1M	Buy	202,793 +15,931	+9%	+$932K	0.22%	89
2016 Q2	$10.3M	Buy	186,862 +9,833	+6%	+$523K	0.22%	96
2016 Q1	$8.94M	Buy	177,029 +3,415	+2%	+$167K	0.2%	100
2015 Q4	$8.75M	Buy	173,614 +5,641	+3%	+$284K	0.21%	102
2015 Q3	$7.92M	Buy	167,973 +2,362	+1%	+$125K	0.23%	94
2015 Q2	$9M	Buy	165,611 +1,076	+0.7%	+$60.3K	0.25%	87
2015 Q1	$9.02M	Buy	164,535 +1,653	+1%	+$93.6K	0.26%	85
2014 Q4	$8.83M	Buy	162,882 +3,164	+2%	+$176K	0.27%	79
2014 Q3	$9.03M	Buy	159,718 +13,452	+9%	+$755K	0.27%	82
2014 Q2	$8.07M	Buy	146,266 +748	+0.5%	+$40.8K	0.28%	76
2014 Q1	$7.88M	Buy	145,518 +37,800	+35%	+$1.96M	0.3%	72
2013 Q4	$5.14M	Sell	107,718 -3,194	-3%	-$146K	0.21%	103
2013 Q3	$5.04M	Buy	110,912 +3,292	+3%	+$150K	0.22%	101
2013 Q2	$4.77M	Buy	+107,620	New	+$4.81M	0.24%	91

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Cambridge Investment Research Advisors's MRK Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Merck (MRK) stake by 14% in Q2 2026, buying an estimated $6.77M and bringing the position to 469,217 shares worth $60.3M. The position accounts for 0.14% of the portfolio, ranked #136.

Cambridge Investment Research Advisors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. 1,498 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Cambridge Investment Research Advisors held 469,217 shares of Merck worth $60.3M as of Q2 2026.
Cambridge Investment Research Advisors bought 57,875 Merck shares in Q2 2026, an estimated $6.77M.
Merck made up 0.14% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #136 holding.
Cambridge Investment Research Advisors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
1,498 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.